Skip to NavigationSkip to content

News

In a bid to boost its rare disease portfolio prospects, Ipsen has revealed its intention to acquire Clementia Pharmaceuticals, with both companies...
The UK Home Office have licensed a drug-checking service for users of illicit substances. The yearlong pilot project, run by the charity Addaction...
The Missouri Supreme Court has ruled that the practice of combining two or more cases in order to allow courts to hear cases they otherwise would...
Roche is set to fully acquire gene therapy Spark Therapeutics after entering into a definitive merger agreement, after the Boards of both companies...
The chairman of the Iranian Food and Drug Administration (FDA) Mehdi Pirsalehi, has said that Iran is ready to export medicines and medical...
-Keytruda's liver cancer failure -A "game-changing osteoasrthritis treatment - AstraZeneca retires the MedImmune brand -Promise of the first new...
The Justice Department and US Securities and Exchanges Commission are investigation healthcare giant Johnson & Johnson over allegations that...
UK drug watchdog The Medicines and Healthcare products Regulatory Agency (MHRA) has warned of the potential side-effects of Neo-mercazole (...
The twins who were genetically modified using the gene editing tool CRISPR may have been changed in a way that could enhance their memory and...
The number of phone calls to US poison control centres over exposures to kratom – an herbal drug with opioid properties and stimulant like effects...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches